CAN
PDLI

Cetera Advisor Networks’s PDL BioPharma, Inc. PDLI Stock Holding History

Cetera Advisor Networks’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-460
Closed -$1K – 3442
2020
Q2 		$1K Buy
+460
New +$1.46K ﹤0.01% 3428
2018
Q4 		– Sell
-16,224
Closed -$42K – 1186
2018
Q3 		$42K Sell
16,224
-700
-4% -$1.72K ﹤0.01% 1121
2018
Q2 		$40K Hold
16,924
– – ﹤0.01% 830
2018
Q1 		$49K Hold
16,924
– – ﹤0.01% 842
2017
Q4 		$45K Sell
16,924
-1,336
-7% -$4.1K ﹤0.01% 978
2017
Q3 		$62K Hold
18,260
– – ﹤0.01% 900
2017
Q2 		$45K Sell
18,260
-420
-2% -$966 ﹤0.01% 908
2017
Q1 		$44K Sell
18,680
-5,920
-24% -$13.1K ﹤0.01% 907
2016
Q4 		$51K Sell
24,600
-14,960
-38% -$41.7K ﹤0.01% 854
2016
Q3 		$133K Buy
39,560
+14,000
+55% +$44.4K 0.01% 997
2016
Q2 		$80K Sell
25,560
-1,748
-6% -$5.83K ﹤0.01% 815
2016
Q1 		$91K Buy
27,308
+5,551
+26% +$17.3K 0.01% 803
2015
Q4 		$77K Buy
21,757
+3,628
+20% +$15.2K ﹤0.01% 808
2015
Q3 		$94K Buy
+18,129
New +$104K 0.01% 775
2015
Q1 		– Sell
-16,629
Closed -$129K – 907
2014
Q4 		$129K Buy
16,629
+500
+3% +$3.96K 0.01% 775
2014
Q3 		$121K Hold
16,129
– – 0.01% 792
2014
Q2 		$156K Buy
16,129
+629
+4% +$5.61K 0.01% 765
2014
Q1 		$129K Sell
15,500
-2,790
-15% -$23.9K 0.01% 746
2013
Q4 		$153K Sell
18,290
-600
-3% -$5.06K 0.01% 713
2013
Q3 		$150K Buy
18,890
+500
+3% +$4.02K 0.01% 653
2013
Q2 		$143K Buy
+18,390
New +$143K 0.01% 575

Other funds holding PDLI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.1B AUM 20.71% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Cetera Advisor Networks's PDLI Position: Q3 2020 in Review

Cetera Advisor Networks sold out of PDL BioPharma, Inc. (PDLI) in Q3 2020, closing a stake of 460 shares — an estimated $1K sold.

Cetera Advisor Networks first reported a position in PDLI in Q2 2013 and held it in 21 quarters. The position peaked at $156K in Q2 2014. 132 funds tracked by Wall St. Rank hold PDLI as of Q3 2020.

  • Cetera Advisor Networks reported no remaining PDL BioPharma, Inc. position as of Q3 2020 after selling out during the quarter.
  • Cetera Advisor Networks sold 460 PDL BioPharma, Inc. shares in Q3 2020, an estimated $1K.
  • Cetera Advisor Networks first reported a position in PDL BioPharma, Inc. in Q2 2013 and held it in 21 quarters.
  • Cetera Advisor Networks's PDL BioPharma, Inc. position peaked at $156K in Q2 2014.
  • 132 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q3 2020.

Based on Cetera Advisor Networks's 13F filing for Q3 2020, filed 13 Nov 2020.